Kaken Pharmaceutical Co., Ltd. (4521.T)
JPY 4133.0
(-0.17%)
JPY 4133.0
(-0.17%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -61.47 Billion JPY | -10.34% |
| 2022 | -55.71 Billion JPY | 2.56% |
| 2021 | -57.17 Billion JPY | 4.48% |
| 2020 | -59.85 Billion JPY | -7.13% |
| 2019 | -55.87 Billion JPY | -29.69% |
| 2018 | -43.08 Billion JPY | -4.51% |
| 2017 | -41.22 Billion JPY | -37.44% |
| 2016 | -29.99 Billion JPY | -20.75% |
| 2015 | -24.83 Billion JPY | -398.65% |
| 2014 | -4.98 Billion JPY | 5.93% |
| 2013 | -5.29 Billion JPY | -373.61% |
| 2012 | -1.11 Billion JPY | -11.91% |
| 2011 | -999 Million JPY | 83.79% |
| 2010 | -6.16 Billion JPY | -389.05% |
| 2009 | -1.26 Billion JPY | 30.54% |
| 2008 | -1.81 Billion JPY | -532.94% |
| 2007 | 419 Million JPY | 127.4% |
| 2006 | -1.52 Billion JPY | -117.12% |
| 2005 | 8.93 Billion JPY | 4.22% |
| 2004 | 8.57 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -48.01 Billion JPY | 4.89% |
| 2023 FY | -61.47 Billion JPY | -10.34% |
| 2023 Q2 | -51.51 Billion JPY | 2.78% |
| 2023 Q1 | -52.98 Billion JPY | 4.89% |
| 2023 Q4 | -61.47 Billion JPY | -29.14% |
| 2023 Q3 | -47.6 Billion JPY | 7.59% |
| 2022 Q3 | -52 Billion JPY | 8.63% |
| 2022 Q2 | -56.91 Billion JPY | -1.37% |
| 2022 Q1 | -56.14 Billion JPY | 1.79% |
| 2022 FY | -55.71 Billion JPY | 2.56% |
| 2022 Q4 | -55.71 Billion JPY | -7.12% |
| 2021 Q4 | -57.17 Billion JPY | -15.47% |
| 2021 Q2 | -58.82 Billion JPY | -3.06% |
| 2021 FY | -57.17 Billion JPY | 4.48% |
| 2021 Q1 | -57.07 Billion JPY | 4.65% |
| 2021 Q3 | -49.51 Billion JPY | 15.82% |
| 2020 Q3 | -51.22 Billion JPY | 10.48% |
| 2020 Q1 | -56.64 Billion JPY | -1.39% |
| 2020 Q2 | -57.21 Billion JPY | -1.01% |
| 2020 Q4 | -59.85 Billion JPY | -16.86% |
| 2020 FY | -59.85 Billion JPY | -7.13% |
| 2019 Q4 | -55.87 Billion JPY | -20.13% |
| 2019 FY | -55.87 Billion JPY | -29.69% |
| 2019 Q3 | -46.51 Billion JPY | 3.09% |
| 2019 Q1 | -43.54 Billion JPY | -1.07% |
| 2019 Q2 | -47.99 Billion JPY | -10.22% |
| 2018 Q3 | -38.15 Billion JPY | 5.79% |
| 2018 Q4 | -43.08 Billion JPY | -12.9% |
| 2018 Q2 | -40.5 Billion JPY | -10.42% |
| 2018 Q1 | -36.68 Billion JPY | 11.01% |
| 2018 FY | -43.08 Billion JPY | -4.51% |
| 2017 Q2 | -38.05 Billion JPY | -14.83% |
| 2017 FY | -41.22 Billion JPY | -37.44% |
| 2017 Q4 | -41.22 Billion JPY | -22.53% |
| 2017 Q3 | -33.64 Billion JPY | 11.6% |
| 2017 Q1 | -33.13 Billion JPY | -10.49% |
| 2016 Q1 | -19.96 Billion JPY | 19.64% |
| 2016 Q4 | -29.99 Billion JPY | -42.8% |
| 2016 Q3 | -21 Billion JPY | 18.55% |
| 2016 Q2 | -25.78 Billion JPY | -29.19% |
| 2016 FY | -29.99 Billion JPY | -20.75% |
| 2015 Q3 | -6.23 Billion JPY | 6.06% |
| 2015 Q1 | -6 Billion JPY | -20.62% |
| 2015 Q4 | -24.83 Billion JPY | -298.68% |
| 2015 FY | -24.83 Billion JPY | -398.65% |
| 2015 Q2 | -6.63 Billion JPY | -10.39% |
| 2014 Q1 | -4.64 Billion JPY | 12.28% |
| 2014 FY | -4.98 Billion JPY | 5.93% |
| 2014 Q4 | -4.98 Billion JPY | 12.29% |
| 2014 Q2 | -3.84 Billion JPY | 17.27% |
| 2014 Q3 | -5.67 Billion JPY | -47.78% |
| 2013 FY | -5.29 Billion JPY | -373.61% |
| 2013 Q4 | -5.29 Billion JPY | -62.12% |
| 2013 Q3 | -3.26 Billion JPY | 44.92% |
| 2013 Q2 | -5.93 Billion JPY | -554.53% |
| 2013 Q1 | -906 Million JPY | 18.96% |
| 2012 Q3 | 1.13 Billion JPY | 258.41% |
| 2012 Q4 | -1.11 Billion JPY | -198.16% |
| 2012 FY | -1.11 Billion JPY | -11.91% |
| 2012 Q2 | -719 Million JPY | -936.05% |
| 2012 Q1 | 86 Million JPY | 108.61% |
| 2011 Q3 | 1.21 Billion JPY | 348.27% |
| 2011 Q1 | 162 Million JPY | 102.63% |
| 2011 Q2 | -491 Million JPY | -403.09% |
| 2011 Q4 | -999 Million JPY | -181.95% |
| 2011 FY | -999 Million JPY | 83.79% |
| 2010 Q1 | -1.45 Billion JPY | -15.56% |
| 2010 Q2 | 98 Million JPY | 106.73% |
| 2010 FY | -6.16 Billion JPY | -389.05% |
| 2010 Q3 | 1.22 Billion JPY | 1144.9% |
| 2010 Q4 | -6.16 Billion JPY | -605.08% |
| 2009 FY | -1.26 Billion JPY | 30.54% |
| 2009 Q3 | -81 Million JPY | 0.0% |
| 2009 Q4 | -1.26 Billion JPY | -1455.56% |
| 2009 Q2 | - JPY | 0.0% |
| 2008 Q4 | -1.81 Billion JPY | -32.99% |
| 2008 FY | -1.81 Billion JPY | -532.94% |
| 2008 Q3 | -1.36 Billion JPY | 0.0% |
| 2007 FY | 419 Million JPY | 127.4% |
| 2006 FY | -1.52 Billion JPY | -117.12% |
| 2005 FY | 8.93 Billion JPY | 4.22% |
| 2004 FY | 8.57 Billion JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 1.22 Billion JPY | 5118.286% |
| Takeda Pharmaceutical Company Limited | 4385.95 Billion JPY | 101.402% |
| Sumitomo Pharma Co., Ltd. | 389.83 Billion JPY | 115.769% |
| Shionogi & Co., Ltd. | -346.47 Billion JPY | 82.257% |
| Wakamoto Pharmaceutical Co.,Ltd. | -3.56 Billion JPY | -1624.803% |
| Nippon Shinyaku Co., Ltd. | -42.15 Billion JPY | -45.825% |
| Eisai Co., Ltd. | -97.93 Billion JPY | 37.228% |
| Morishita Jintan Co., Ltd. | -667 Million JPY | -9116.492% |
| Hisamitsu Pharmaceutical Co., Inc. | -51.82 Billion JPY | -18.628% |
| Mochida Pharmaceutical Co., Ltd. | -32.92 Billion JPY | -86.732% |
| Fuso Pharmaceutical Industries,Ltd. | 7.6 Billion JPY | 908.656% |
| Nippon Chemiphar Co., Ltd. | 7.78 Billion JPY | 890.053% |
| Tsumura & Co. | 1.61 Billion JPY | 3906.44% |
| Kissei Pharmaceutical Co., Ltd. | -44.16 Billion JPY | -39.207% |
| Torii Pharmaceutical Co., Ltd. | -34.43 Billion JPY | -78.511% |
| Towa Pharmaceutical Co., Ltd. | 172.7 Billion JPY | 135.595% |
| Fuji Pharma Co., Ltd. | 26.62 Billion JPY | 330.897% |
| Zeria Pharmaceutical Co., Ltd. | 28.98 Billion JPY | 312.113% |
| KYORIN Holdings, Inc. | 7.06 Billion JPY | 970.737% |
| Taiko Pharmaceutical Co.,Ltd. | 704 Million JPY | 8832.102% |
| Daito Pharmaceutical Co.,Ltd. | 5.99 Billion JPY | 1125.935% |
| SymBio Pharmaceuticals Limited | -6.51 Billion JPY | -843.286% |
| MedRx Co., Ltd | -1.72 Billion JPY | -3474.07% |
| Mizuho Medy Co.,Ltd. | -8.71 Billion JPY | -605.263% |
| Solasia Pharma K.K. | -668 Million JPY | -9102.695% |
| Modalis Therapeutics Corporation | -1.47 Billion JPY | -4079.241% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | -7.25 Billion JPY | -747.567% |
| Sawai Group Holdings Co., Ltd. | 56.52 Billion JPY | 208.761% |
| Cyfuse Biomedical K.K. | -2.96 Billion JPY | -1976.282% |
| Toho Holdings Co., Ltd. | -98.42 Billion JPY | 37.545% |
| Koa Shoji Holdings Co.,Ltd. | -11.12 Billion JPY | -452.347% |